Pacira Pharm Inc (PCRX) 37.76 $PCRX New Research: Opioid

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2016 at 10:16 AM

Pacira Pharm Inc (PCRX) 37.76 $PCRX

New Research: Opioid Addiction and Dependence After Surgery is Significantly Higher than Previously Known
GlobeNewswire - Mon Aug 01, 6:30AM CDT
Vast Majority of Surgeons Feel Pressure to Prescribe More Opioids than Patients Need
PCRX: 37.76 (+0.18)

Technical Analysis on Drugs - Generic Equities -- Akorn, Ironwood Pharma, Catalyst Pharma, and Pacira Pharma
PR Newswire - Fri Jun 10, 7:00AM CDT
On Thursday, June 09, 2016, the NASDAQ Composite ended the trading session at 4,958.62, down 0.32%; the Dow Jones Industrial Average edged 0.11% lower to finish at 17,985.19; and the S&P 500 closed at 2,115.48, down 0.17%. ActiveWallSt.com has initiated coverage on the following equities: Akorn Inc. (NASDAQ: AKRX), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX), and Pacira Pharmaceuticals Inc. (NASDAQ: PCRX). Learn more about these stocks by accessing their free trade alerts at:
IRWD: 13.94 (unch), CPRX: 0.74 (-0.02), AKRX: 32.81 (-0.99), PCRX: 37.76 (+0.18)

Pacira Pharmaceuticals, Inc. to Present at the Jefferies 2016 Healthcare Conference
GlobeNewswire - Tue May 31, 6:30AM CDT
Pacira Pharmaceuticals, Inc. (NASDAQ

CRX) today announced that Dave Stack, Chief Executive Officer and Chairman of Pacira Pharmaceuticals, is scheduled to present at the Jefferies 2016 Healthcare Conference at 9 a.m. ET on Tuesday, June 7, 2016, in New York. Mr. Stack is expected to present an overview of the company.
PCRX: 37.76 (+0.18)

Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
GlobeNewswire - Tue May 03, 6:30AM CDT
Pacira Pharmaceuticals, Inc. (NASDAQ

CRX) today announced that Jim Scibetta, President of Pacira Pharmaceuticals, is scheduled to present at the Bank of America Merrill Lynch 2016 Health Care Conference at 8:40 a.m. PT (11:40 a.m. ET) on Tuesday, May 10, 2016, in Las Vegas. Mr. Scibetta is expected to present an overview of the company.
PCRX: 37.76 (+0.18)

Pacira Pharmaceuticals Inc.'s Double-Digit Drop Explained
Sean Williams, The Motley Fool - Motley Fool - Mon May 02, 3:02PM CDT
Image source: NIH Image Gallery via Flickr. What: Shares of Pacira Pharmaceuticals , a specialty pharmaceutical company primarily focused on the development of medicines to help in the acute hospital care setting, dipped by as much as 10%...
PCRX: 37.76 (+0.18)

Pacira reports 1Q loss
Automated Insights - Mon May 02, 6:40AM CDT
PARSIPPANY, N.J. (AP) _ Pacira Pharmaceuticals Inc. (PCRX) on Monday reported a first-quarter loss of $3.9 million, after reporting a profit in the same period a year earlier.
PCRX: 37.76 (+0.18)

Pacira Pharmaceuticals, Inc. Reports First Quarter 2016 Financial Results
GlobeNewswire - Mon May 02, 6:34AM CDT
-- Total Net Revenues Up 12 Percent Year-Over-Year --
PCRX: 37.76 (+0.18)

Pacira Pharmaceuticals Appoints Charles A. Reinhart, III, as Chief Financial Officer
GlobeNewswire - Tue Apr 19, 7:00AM CDT
Pacira Pharmaceuticals, Inc. (NASDAQ

CRX) today announced the appointment of Charles A. Reinhart, III, to the position of Chief Financial Officer. Mr. Reinhart will be responsible for overseeing all financial and capital market activities at Pacira, including accounting, financial reporting, financial planning and analysis and investor relations. In this position, he will succeed former Chief Financial Officer Jim Scibetta, who is currently President, and will report to Dave Stack, Chief Executive Officer and Chairman. Mr. Reinhart will start in this new role effective Tuesday, May 3, 2016.
PCRX: 37.76 (+0.18)

Pacira Pharmaceuticals (PCRX) is Overbought: Is A Drop Coming?
Zacks Equity Research - Zacks Investment Research - Fri Apr 15, 7:48AM CDT
Pacira Pharmaceuticals, Inc. (PCRX) has moved higher as of late, but there could definitely be trouble on the horizon for this company
PCRX: 37.76 (+0.18)

Pacira Pharmaceuticals Announces Timing for First Quarter 2016 Financial Results Webcast and Conference Call
GlobeNewswire - Thu Apr 14, 6:30AM CDT
Pacira Pharmaceuticals, Inc. (NASDAQ

CRX) today announced that financial results for the company's first quarter ended March 31, 2016 will be released before the market opens on Monday, May 2, 2016. The Pacira management team will host a conference call to discuss the company's financial results and recent and upcoming developments on Monday, May 2, 2016, at 9 a.m. ET. The call can be accessed by dialing 1-877-845-0779 (domestic) or 1-720-545-0035 (international) ten minutes prior to the start of the call and providing the Conference ID 54803652.
PCRX: 37.76 (+0.18)

Pacira Pharmaceuticals Appoints Robert Weiland as Chief Commercial Officer
GlobeNewswire - Tue Apr 05, 6:30AM CDT
Pacira Pharmaceuticals, Inc. (NASDAQ

CRX) today announced the appointment of Robert Weiland to the position of Chief Commercial Officer. Mr. Weiland will be responsible for oversight of the commercial activities for EXPAREL (bupivacaine liposome injectable suspension), which include marketing, sales, national accounts, training and commercial operations and analytics. Mr. Weiland will report to Jim Scibetta, President and Chief Financial Officer.
PCRX: 37.76 (+0.18)

Pacira (PCRX): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 9:05AM CDT
Pacira Pharmaceuticals, Inc. (PCRX) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
PCRX: 37.76 (+0.18)

PixarBio's NeuroRelease(TM) A Revolutionary Non Addictive Pain Treatment Draws Pain Industry Star Sales Executive David Kaplan as Global VP of Sales & Marketing
BusinessWire - Wed Mar 09, 5:00AM CST
PixarBio Corporation inventors of NeuroRelease, a 14 day non-addictive post-surgical pain treatment with expected FDA approval in 2018, announced today the appointment of David Kaplan as Vice President of Global Sales and Marketing.
PCRX: 37.76 (+0.18)

Pacira Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
GlobeNewswire - Tue Mar 08, 6:30AM CST
Pacira Pharmaceuticals, Inc. (NASDAQ

CRX) today announced that Dave Stack, chief executive officer and chairman of Pacira Pharmaceuticals, is scheduled to present at the Barclays Global Healthcare Conference at 9 a.m. ET on Tuesday, March 15, 2016, in Miami. Mr. Stack is expected to present an overview of the company.
PCRX: 37.76 (+0.18)

CTI BioPharma's Myelofibrosis Drug on Full Clinical Hold
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 3:04PM CST
CTI BioPharma Corp. (CTIC) announced that the FDA has placed the company's Investigational New Drug (IND) application for pacritinib on a full clinical hold.
GILD: 80.90 (+0.44), MYL: 46.00 (-0.74), CTIC: 0.33 (-0.01), PCRX: 37.76 (+0.18)

Catalyst (CPRX) Initiates Study on Firdapse for MuSK-MG
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 3:25PM CST
Catalyst Pharmaceuticals, Inc. (CPRX) announced the initiation of a well-controlled study evaluating the efficacy, safety and tolerability of Firdapse for the treatment of MuSK-MG.
EARS: 4.17 (+0.03), CPRX: 0.74 (-0.02), CORT: 5.76 (-0.01), PCRX: 37.76 (+0.18)

Shire's NDA Resubmission for Lifitegrast Accepted by FDA
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 3:15PM CST
Shire plc (SHPG) announced that the FDA has acknowledged the receipt of the company's New Drug Application (NDA) for its pipeline candidate, lifitegrast.
AGN: 253.07 (-1.79), SHPG: 202.27 (+8.27), CORT: 5.76 (-0.01), PCRX: 37.76 (+0.18)

Conatus Up on Fast Track Status for Emricasan in the U.S.
Zacks Equity Research - Zacks Investment Research - Thu Feb 04, 1:40PM CST
Shares of Conatus Pharmaceuticals Inc. (CNAT) soared 22.5% after the company announced that the FDA has granted Fast Track designation to the company's lead pipeline candidate, emricasan,
CNAT: 2.35 (+0.06), CORT: 5.76 (-0.01), PCRX: 37.76 (+0.18), BIOD: 0.40 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lavior and CR Fitness Team for Wellness Reach

Botanical Care Meets Gym Life in the Southeast Lavior, the botanical whiz kids of wound and skin care out of Miami, are shaking hands with CR Fitness, Crunch's big-time franchise operator carrying the flag across the Southeast. They’ve ironed out a deal that’ll park Lavior’s products in more than 60 gyms covering Florida, Georgia, North Carolina, and Texas. It’s a...

Lawsuit Targets Electrical Consultants' Labor Practices

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

Spencer Peterman Hosts Eco-Friendly Wood Bowl Sale

Just when you think you've seen it all in the world of craftsmanship, along comes a dynamo like Spencer Peterman. For over 25 years, he's been turning what others discard into treasures. Fallen trees? Most folks see firewood. Spencer sees a future masterpiece. And now, he’s rolling out the welcome mat for his loyal customers with a special sale that runs until December...

Annex Brands Grows with Bastrop's PostalAnnex Opening

New PostalAnnex Location Opens in Bastrop, TX Here's a fresh chapter in the books for Annex Brands, Inc. They've just cut the ribbon on a brand spanking new PostalAnnex in Bastrop, Texas, handing the reins over to eager fresh faces, Chetan Modi and Karan Desai. And you know what? This ain't just any regular location. It's a one-stop-shop for anything you could need, from...

U.N. Leaders Converge at NYSE, Forus Soars to $3B Valuation

A Busy Morning at the NYSE with Key Guests and Global Events In a world where high-stakes diplomacy and roaring market bells go hand in hand, today brings the U.S. Secretary of State, Marco Rubio, to the New York Stock Exchange. With the 81st Session of the United Nations General Assembly shaking up the Big Apple, the city finds itself at the intersection of politics and...

Anixa Expands Global Footprint with Aussie Patent

Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...

Navigating AI's New Era: Dresner's 2026 Findings

Big Insights in the AI World of 2026 Well folks, if there's one thing making waves in the boardrooms this year, it's AI. Dresner Advisory Services just threw down a gauntlet for companies with their fresh batch of reports focused on the dizzying world of AI. They ripped right into it, exploring how firms can bag a heap of benefits and deal with the hurdles that come with...

Castillo Engineering Gears Up with New VP Appointments

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Lititz Mutual Embraces AI with Guidewire ProNavigator

It's not every day you see a company like Lititz Mutual making moves in the artificial intelligence (AI) arena. Based out of Lititz, Pennsylvania, this insurance firm has decided to shake things up with Guidewire's ProNavigator AI assistant. Forging New Paths in Insurance Lititz Mutual is set to inject some serious tech into their operations. The goal? Make life easier...

NACD Honors Top Board Leaders with 2026 Awards

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...